During the past decade, Academic Unit of Bone Metabolism conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Academic Unit of Bone Metabolism" #1 collaborator was "University of Sheffield" with 3 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Academic Unit of Bone Metabolism" are "Carcinoid Syndrome" (1 trials), "Hypophosphatasia" (1 trials), "Obesity" (1 trials) and "Revision Surgery of Total Hip Arthroplasty" (1 trials). Many other conditions were trialed in "Academic Unit of Bone Metabolism" in a lesser frequency.

Most popular intervention types in "Academic Unit of Bone Metabolism" are "Other" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Denosumab" (1 trials), "Placebo" (1 trials), "Study visit procedures" (1 trials) and "no intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Academic Unit of Bone Metabolism" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Academic Unit of Bone Metabolism". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Academic Unit of Bone Metabolism, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Academic Unit of Bone Metabolism, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".